SUNLENCA
Gilead Sciences Ireland UC
Mark For: SUNLENCA® trademark registration is intended to cover the categories of
| Website |
www.gilead.com
 |
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88823358 |
| Registration Number | 6578830 |
| Mark Literal Elements | SUNLENCA |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2020-11-24 |
| Basis | 1(b) 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | Yes |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Gretchen R. Stroud |
Timeline
| 2020-03-05 | Application Filed |
| 2020-03-09 | Location: NEW APPLICATION PROCESSING |
| 2020-03-09 | Status: Live/Pending |
| 2020-03-09 | Transaction Date |
| 2020-07-08 | Trademark Registered |
| 2020-09-29 | Published |
| 2020-11-24 | Location: INTENT TO USE SECTION |
| 2021-03-31 | Status: A first request for extension of time to file a Statement of Use has been granted. |
| 2021-12-07 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Gilead Sciences Ireland UC |
| Address | IDA BUSINESS AND TECHNOLOGY PARK CARRIGTOHILL, CO. CORK IRELAND |
| Legal Entity Type | Unlimited Company |
| Legal Entity State | IRELAND |
Documents
 Application | 2020-03-05 | |
| Drawing | 2020-03-05 | |
| Offc Action Outgoing | 2020-05-28 | |
| XSearch Search Summary | 2020-05-28 | |
| Response to Office Action | 2020-07-22 | |
| Amendment and Mail Process Complete | 2020-08-13 | |
| TRAM Snapshot of App at Pub for Oppostn | 2020-08-22 | |
| Notice of Publication | 2020-09-09 | |
| Notification Of Notice of Publication | 2020-09-09 | |
| OG Publication Confirmation | 2020-09-29 | |
| Notice of Allowance | 2020-11-24 | |
| Extension of Time to File SOU | 2021-03-31 | |
| ITU Extension Approval | 2021-04-02 | |
| ITU Unit Action | 2021-04-02 | |
| Extension of Time to File SOU | 2021-09-28 | |
| ITU Extension Approval | 2021-09-30 | |
| ITU Unit Action | 2021-09-30 | |
| Teas Delete 1(b) Basis | 2021-10-12 | |
| Amendment to Delete or Correct Basis | 2021-11-03 | |
| ITU Unit Action | 2021-11-03 | |
| Prosecution History for Canceling NOA | 2021-11-03 | |
| Registration Certificate | 2021-12-07 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders |
| GS0051 | Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| REGISTERED-PRINCIPAL REGISTER | 2021-12-07 | |
| ASSIGNED TO EXAMINER | 2021-11-10 | 61638 |
| 1(B) BASIS DELETED; PROCEED TO REGISTRATION | 2021-11-02 | 66530 |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-10-27 | 66530 |
| TEAS DELETE 1(B) BASIS RECEIVED | 2021-10-12 | |
| NOTICE OF ALLOWANCE CANCELLED | 2021-10-12 | 66530 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-09-30 | |
| TEAS EXTENSION RECEIVED | 2021-09-28 | |
| SOU EXTENSION 2 GRANTED | 2021-09-28 | 98765 |
| SOU EXTENSION 2 FILED | 2021-09-28 | 98765 |
| EXTENSION 2 GRANTED | 2021-09-28 | 98765 |
| EXTENSION 2 FILED | 2021-09-28 | 98765 |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-04-02 | |
| TEAS EXTENSION RECEIVED | 2021-03-31 | |
| SOU EXTENSION 1 GRANTED | 2021-03-31 | 98765 |
| SOU EXTENSION 1 FILED | 2021-03-31 | 98765 |
| EXTENSION 1 GRANTED | 2021-03-31 | 98765 |
| EXTENSION 1 FILED | 2021-03-31 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-11-24 | |
| PUBLISHED FOR OPPOSITION | 2020-09-29 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-09-29 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-09-09 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-08-21 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-08-12 | 74221 |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-08-12 | 74221 |
| ASSIGNED TO LIE | 2020-08-07 | 74221 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-07-22 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-05-28 | 6325 |
| NON-FINAL ACTION WRITTEN | 2020-05-28 | 66384 |
| NON-FINAL ACTION E-MAILED | 2020-05-28 | 6325 |
| ASSIGNED TO EXAMINER | 2020-05-24 | 66384 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-03-11 | |
| NEW APPLICATION ENTERED IN TRAM | 2020-03-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 